Back to results
US 2021/0276952 A1Published application
Novel compounds
OwnerKate SMITH, Alexis DENIS +3inventors
InventorsKate SMITH, Alexis DENIS, Nerina DODIC, John LIDDLE, David LOMAS
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds, compositions, combinations and medicaments containing said compounds and processes for their preparation. The invention also relates to the use of said compounds, combinations, compositions and medicaments, for example as modulators of alpha I antitrypsin and treating diseases associated with alpha antitrypsin, particularly liver diseases.
Claims21
A compound having a molecular weight of 1000 Daltons or less that is capable of inhibiting α1-antitrypsin polymerisation;
- or a pharmaceutically acceptable solvate, complex, tautomer, isotopically labelled derivative or prodrug thereof.
2-33. (canceled)
Dependencies are inferred from the claim text.